Genetic Technologies Regains Compliance with Nasdaq Listing Requirement, Works to Meet Another Requirement | GenomeWeb

NEW YORK (GenomeWeb) – Genetic Technologies said today that it regained compliance with a listing requirement for continued listing on the Nasdaq, while the exchange has extended a deadline for the company to regain compliance with another requirement. 

In August Nasdaq sent a letter to Genetic Technologies informing the firm that it wasn't in compliance with a Nasdaq listing rule calling for a minimum $1 bid on the company's shares, and as a result the firm faced a possible delisting action. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.